Gilead Sciences Aktie

60,14EUR
+0,16EUR
+0,27%
21.01.2022
68,51USD
+0,70USD
+1,03%
21.01.2022

WKN: 885823 / ISIN: US3755581036 / Symbol: GILD

  Kaufen  
Verkaufen
oder
Werbung

Gilead Sciences Aktien News

20.01.22
Gilead klagt wegen gefälschter HIV-Medikamente (Der Aktionär)
18.01.22
Gilead Sciences (GILD) Stock Sinks As Market Gains: What You Should Know (Zacks)
11.01.22
Gilead Sciences (GILD) Gains But Lags Market: What You Should Know (Zacks)
11.01.22
Gilead (GILD) Partners With Merck for Keytruda in NSCLC Study (Zacks)
06.01.22
: Gilead Sciences downgraded to equal weight at Morgan Stanley (MarketWatch)
06.01.22
Is Eventide Gilead Fund N (ETGLX) a Strong Mutual Fund Pick Right Now? (Zacks)
05.01.22
Why Gilead (GILD) is Poised to Beat Earnings Estimates Again (Zacks)
03.01.22
Gilead Sciences (GILD) Stock Sinks As Market Gains: What You Should Know (Zacks)
30.12.21
Zacks Investment Ideas feature highlights: Gilead Sciences, Regeneron and Avid Bioservices (Zacks)
30.12.21
Gilead Sciences (GILD) Outpaces Stock Market Gains: What You Should Know (Zacks)
29.12.21
Has Gilead Sciences (GILD) Outpaced Other Medical Stocks This Year? (Zacks)
29.12.21
Gilead (GILD) Hits Fresh High: Is There Still Room to Run? (Zacks)
28.12.21
Can Veklury Sales Retain Momemtum for Gilead (GILD) in 2022? (Zacks)
23.12.21
Gilead Sciences (GILD) Gains But Lags Market: What You Should Know (Zacks)
16.12.21
Gilead Sciences (GILD) Gains As Market Dips: What You Should Know (Zacks)
14.12.21
Awakn Life Sciences Appoints Former EVP & Chief Commercial Officer of Gilead Sciences, Paul Carter, as Independent Member of its Board of Directors (Newsfile)
10.12.21
Gilead Sciences (GILD) Stock Sinks As Market Gains: What You Should Know (Zacks)
07.12.21
Is Gilead Sciences Stock a Buy Now? (MotleyFool)
30.11.21
Amazon's (AMZN) AWS Gets Selected by Gilead, Boosts Clientele (Zacks)
30.11.21
The Zacks Analyst Blog Highlights: Accenture, Raytheon, Becton, Dickinson and Co, Boeing and Gilead Sciences (Zacks)
26.11.21
Gilead Sciences (GILD) Stock Gains 20% YTD: What Lies Ahead? (Zacks)
24.11.21
Gilead (GILD) Gets EU Nod for Breast Cancer Drug, Trodelvy (Zacks)
22.11.21
Gilead (GILD) Files BLA for Bulevirtide for Hepatitis Delta Virus (Zacks)
19.11.21
Gilead (GILD) Exercises Options to Three Arcus Programs (Zacks)
19.11.21
: Gilead Sciences upgraded to outperform from market perform at BMO Capital (MarketWatch)
18.11.21
Arcus Biosciences shares rocket premarket after Gilead exercises options for 3 cancer programs for $725 million (Market Watch)
18.11.21
Gilead exercises option to 3 Arcus Biosciences clinical programs for $725 mln (MarketWatch)
12.11.21
Gilead (GILD), Everest Medicine Report Phase II Cancer Study Data (Revised) (Zacks)
11.11.21
Gilead (GILD), Everest Medicine Report Phase II Cancer Study Data (Zacks)
30.10.21Gilead Sciences stellte Quartalsergebnis zum abgelaufenen Jahresviertel vor (finanzen.net)
29.10.21
Gilead Sciences (GILD) Q3 2021 Earnings Call Transcript (MotleyFool)
29.10.21
: Gilead Sciences earnings and outlook top Street views (MarketWatch)
29.10.21
Gilead (GILD) Q3 Earnings Beat on Increased Veklury Sales (Zacks)
28.10.21
Gilead Sciences (GILD) Q3 Earnings and Revenues Surpass Estimates (Zacks)
27.10.21
Why Gilead (GILD) Might Surprise This Earnings Season (Zacks)
26.10.21Ausblick: Gilead Sciences stellt Zahlen zum jüngsten Quartal vor (finanzen.net)
25.10.21
Gilead (GILD) to Report Q3 Earnings: Is a Beat in the Cards? (Zacks)
22.10.21
Gilead Sciences (GILD) Gains As Market Dips: What You Should Know (Zacks)
21.10.21
Gilead Sciences (GILD) Expected to Beat Earnings Estimates: What to Know Ahead of Q3 Release (Zacks)
18.10.21
Gilead (GILD) Breast Cancer Drug Gets Positive CHMP Opinion (Zacks)
Seite: 123456789...13

Gilead Sciences News

Gilead Sciences News: auf dieser Seite finden Sie alle Gilead Sciences News und Nachrichten zur Gilead Sciences Aktie. Dies beinhaltet die Agentur-Feeds auf finanzen.net, aber auch Gilead Sciences News auf einer Vielzahl externer Seiten. Externe Links sind am entsprechenden Link-Symbol zu erkennen. Um Gilead Sciences News auf externen Seiten zu lesen, folgen Sie einfach dem entsprechenden Link.
Werbung
finanzen.net zero
finanzen.net zero

Oskar

ETF-Sparplan

Oskar ist der einfache und intelligente ETF-Sparplan. Er übernimmt die ETF-Auswahl, ist steuersmart, transparent und kostengünstig.
Zur klassischen Ansicht wechseln